Review Article
Comprehensive Management of Upper Tract Urothelial Carcinoma
Table 3
Studies for robotic-assisted laparoscopic nephrectomy.
| Study | No. of patients | Conversions | Follow-up | Outcomes |
| Gettman et al. [28] | 13 | 1 to LN | 13 months | RALN is feasible and safely performed | Phillips et al. [30] | 12 | 2 one to HALN and 1 to OS | 12 months | RALN is safe, feasible, and reproducible | Caruso et al. [31] | 10 | 1 to LN | 12 months | RALN safe and feasible procedure in patients with small exophytic masses | Kaul et al. [32] | 10 | No conversions | 15 months | RALN is a viable alternative to LN for patients with small exophytic masses | Deane et al. [33] | 10 | No conversions | 16 months | No difference between RALN and LN as regarding PT,IBL and MWIT |
|
|
RALN: robotic-assisted laparoscopic nephrectomy,
LN: laparoscopic nephrectomy, OS: open surgery, PT: procedure time,
IBL: intraoperative blood loss, MWIT: mean warm ischemia time.
|